211 related articles for article (PubMed ID: 2573739)
1. Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.
Dodon MD; Bernard A; Gazzolo L
J Virol; 1989 Dec; 63(12):5413-9. PubMed ID: 2573739
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
[TBL] [Abstract][Full Text] [Related]
3. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
4. Activation of human T lymphocytes through CD3 and CD2 (T11) with anti-CD3-coupled sheep erythrocytes.
Ocklind G
Scand J Immunol; 1988 May; 27(5):609-13. PubMed ID: 2897712
[TBL] [Abstract][Full Text] [Related]
5. Activation of human thymocytes by antibodies to the CD3/T-cell receptor complex: triggering of different epitopes results in different signals.
Schwinzer R; Sommermeyer H; Schlitt HJ; Schmidt RE; Wonigeit K
Cell Immunol; 1991 Sep; 136(2):318-28. PubMed ID: 1714794
[TBL] [Abstract][Full Text] [Related]
6. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway.
Kimata JT; Palker TJ; Ratner L
J Virol; 1993 Jun; 67(6):3134-41. PubMed ID: 7684460
[TBL] [Abstract][Full Text] [Related]
7. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
[TBL] [Abstract][Full Text] [Related]
8. Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen.
Beyers AD; Barclay AN; Law DA; He Q; Williams AF
Immunol Rev; 1989 Oct; 111():59-77. PubMed ID: 2576418
[TBL] [Abstract][Full Text] [Related]
9. Do CD2 and CD3-TCR T-cell activation pathways function independently?
Kabelitz D
Immunol Today; 1990 Feb; 11(2):44-7. PubMed ID: 1970736
[TBL] [Abstract][Full Text] [Related]
10. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
Stohl W; Linker-Israeli M
Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
[TBL] [Abstract][Full Text] [Related]
12. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of CD2-negative T cells by staphylococcal enterotoxin superantigens.
Duan XC; Kabelitz D
Immunol Lett; 1991 Aug; 29(3):219-22. PubMed ID: 1685147
[TBL] [Abstract][Full Text] [Related]
14. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
15. Decreased TcR-CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR-CD3- CD2+ natural killer cells.
Alés-Martínez JE; Alvarez-Mon M; Merino F; Bonilla F; Martínez C; Durántez A; De la Hera A
Eur J Immunol; 1988 Nov; 18(11):1827-30. PubMed ID: 2462502
[TBL] [Abstract][Full Text] [Related]
16. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
[TBL] [Abstract][Full Text] [Related]
17. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
18. Differential immunomodulation by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell activation: dependence upon the individual anti-CD3 monoclonal antibody used for activation.
Stohl W; Posnett DN; Chiorazzi N
Cell Immunol; 1988 Oct; 116(1):73-85. PubMed ID: 2458845
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cells promote anti-CD3-induced T-cell proliferation via cell-cell contact mediated by LFA-1 and CD2.
Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; De Waal RM
Scand J Immunol; 1993 Nov; 38(5):435-44. PubMed ID: 7901894
[TBL] [Abstract][Full Text] [Related]
20. The classical and alternate pathways of T cell activation are impaired in leprosy.
Muthukkaruppan V; Chakkalath HR; Malarkannan S
Immunol Lett; 1988 Sep; 19(1):55-8. PubMed ID: 2903849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
